X0708 D/A LIVE 0000799698 CYTRX CORP 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA CALIFORNIA 90049 (310) 826-5648 DELAWARE None None Corporation true John Caloz 11726 San Vicente Boulevard Suite 650 Los Angeles CA CALIFORNIA 90049 Executive Officer Chief Financial Officer Stephen Snowdy 11726 San Vicente Boulevard Suite 650 Los Angeles CA CALIFORNIA 90049 Executive Officer Chairman and Chief Executive Officer Cary Claiborne 11726 San Vicente Boulevard Suite 650 Los Angeles CA CALIFORNIA 90049 Director Joel Caldwell 11726 San Vicente Boulevard Suite 650 Los Angeles CA CALIFORNIA 90049 Director Jennifer Simpson 11726 San Vicente Boulevard Suite 650 Los Angeles CA CALIFORNIA 90049 Director Pharmaceuticals Decline to Disclose 06b true 0001493152-21-018025 2021-07-13 true true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 4TH FLOOR NEW YORK NY NEW YORK 10022 NY NEW YORK false 18240000 8240000 10000000 Represents 8,240 shares of Series C 10.00% Convertible Preferred Stock at $1,000 per share and preferred investment options ("PIOs") to purchase up to 11,363,637 shares of common stock, exercise price of $0.88 per share, initially sold on 7/13/2021. false 1 1281600 true 0 Consists of: $600,000 cash fee (6% of the aggregate gross proceeds), $75,000 in reimbursable non-accountable expenses, $6,600 in escrow fees and $600,000, the maximum additional cash fee payable to the Agent, subject to the exercise of PIOs for cash. 0 false CYTRX CORP /s/ John Caloz John Caloz Chief Financial Officer 2022-07-28